Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Grau

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Chemotherapy|January 1, 1987
Evolution of acute lymphoblastic leukemia in mice treated with carrier-bound methotrexate and levamisoleL Soriano, M P Rivera-Fillat, M R Grau-Oliete
Revista Espanola De Fisiologia|March 1, 1984
[Method for selecting cells during various phases of the mitotic cycle]J Rigau-Lloveras, M R Grau-Oliete, M P Rivera-Fillat
Cell Biochemistry and Function|March 1, 1992
Simultaneous changes in various mechanisms that mediate the cell incorporation of folate compounds account for low levels of resistance to methotrexateF Cavalcanti, N Calvo, M R Grau-Oliete, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|June 17, 2010
Improved therapeutic responses for liposomal doxorubicin targeted via thrombospondin peptidomimetics versus untargeted doxorubicinM P Rivera-Fillat, F Reig, E M Martínez, et al.
International Journal of Cancer|October 21, 1993
Role of cell cholesterol in modulating vincristine uptake and resistanceJ Pallarés-Trujillo, C Domènech, M R Grau-Oliete, et al.
British Journal of Pharmacology|April 1, 1988
Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristineM P Rivera-Fillat, J Pallarés-Trujillo, C Domènech, et al.
European Journal of Pharmacology|June 1, 1993
Vincristine cellular pharmacokinetic changes associated with multidrug resistanceC Domènech, G Fierro-Durán, L Rodríguez, et al.
Archiv Der Pharmazie|December 1, 1995
Sensitizing properties of new N-(2-arylalkyl) propionamides in drug-sensitive and multidrug-resistant tumor cellsF Ros, R García, M P Rivera-Fillat, et al.
Archiv Der Pharmazie|November 25, 2000
Synthesis of a series of 3-cyanopropionamides and 4-imino-gamma-butyrolactams and evaluation of their function as modulators of multidrug resistanceF Ros, R García, P Gallego, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Chemotherapy|January 1, 1987
Evolution of acute lymphoblastic leukemia in mice treated with carrier-bound methotrexate and levamisoleL Soriano, M P Rivera-Fillat, M R Grau-Oliete
Revista Espanola De Fisiologia|March 1, 1984
[Method for selecting cells during various phases of the mitotic cycle]J Rigau-Lloveras, M R Grau-Oliete, M P Rivera-Fillat
Cell Biochemistry and Function|March 1, 1992
Simultaneous changes in various mechanisms that mediate the cell incorporation of folate compounds account for low levels of resistance to methotrexateF Cavalcanti, N Calvo, M R Grau-Oliete, et al.
Journal of Peptide Science : an Official Publication of the European Peptide Society|June 17, 2010
Improved therapeutic responses for liposomal doxorubicin targeted via thrombospondin peptidomimetics versus untargeted doxorubicinM P Rivera-Fillat, F Reig, E M Martínez, et al.
International Journal of Cancer|October 21, 1993
Role of cell cholesterol in modulating vincristine uptake and resistanceJ Pallarés-Trujillo, C Domènech, M R Grau-Oliete, et al.
British Journal of Pharmacology|April 1, 1988
Comparative uptake, retention and action of vincristine, vinblastine and vindesine on murine leukaemic lymphoblasts sensitive and resistant to vincristineM P Rivera-Fillat, J Pallarés-Trujillo, C Domènech, et al.
European Journal of Pharmacology|June 1, 1993
Vincristine cellular pharmacokinetic changes associated with multidrug resistanceC Domènech, G Fierro-Durán, L Rodríguez, et al.
Archiv Der Pharmazie|December 1, 1995
Sensitizing properties of new N-(2-arylalkyl) propionamides in drug-sensitive and multidrug-resistant tumor cellsF Ros, R García, M P Rivera-Fillat, et al.
Archiv Der Pharmazie|November 25, 2000
Synthesis of a series of 3-cyanopropionamides and 4-imino-gamma-butyrolactams and evaluation of their function as modulators of multidrug resistanceF Ros, R García, P Gallego, et al.
Pageof 1